Manhattan Research Announces Top 10 Product Sites Visited by Physicians

Diabetes sites gain popularity as treatment options change

NEW YORK, August 25, 2008 /PRNewswire/ -- Diabetes treatment brand sites from Januvia, Actos, Byetta, and Avandia are among the top pharmaceutical product websites in terms of primary care physician visitation, according to a new study from pharmaceutical and healthcare market research company Manhattan Research.

Breaking into this year's top product site list are Actos, Actonel, Amitiza, and Aciphex, proving to be successful in increasing physician awareness online. Other brands with sites that made strides in physician visitation are Chantix, jumping from the fourth to third position, and Gardasil, moving up three spots from last year's list.

 

    Top 10 Pharma Product Websites among Physicians in 2008
    Ranked by Number of U.S. Primary Care Physician Visitors

    Position  Product

    1.        Januvia
    2.        Actos
    3.        Chantix
    4.        Gardasil
    5.        Actonel
    6.        Vytorin
    7.        Amitiza
    8.        Byetta
    9.        Avandia
    10.       Aciphex


    Source: ePharma Physician(R) v8.0 (2008)

"This year's rankings show that market events, rather than just advertising alone, can be critical drivers to brand websites," points out Meredith Abreu Ressi, VP of Research at Manhattan Research. "Pharmaceutical companies need to ensure that brand websites contain the latest, most accurate content possible and can be found relatively easily by physicians using search engines to research pharmaceutical information."

The ePharma Physician(R) v8.0 study and its accompanying advisory service focus on physician usage and opinions of online pharmaceutical and biotech information and feature data on a broad spectrum of life sciences companies including GlaxoSmithKline, Johnson & Johnson, Pfizer, Teva, UCB, Amgen, and Watson.

About ePharma Physician(R) v8.0

ePharma Physician(R) v8.0 was conducted via online survey methodology in Q2 2008 among 1,681 online practicing U.S. physicians. The study and advisory service product has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit and provides in-depth analysis of top product and corporate pharmaceutical websites, health portals, online journal sites, specialty- specific sites, newsletters, and society sites.

Marketers interested in learning more about the latest digital sales and professional marketing trends from ePharma Physician(R) v8.0 are invited to attend a webcast from Manhattan Research on Tuesday, August 26, 2008, at 11 a.m. and 3 p.m., EDT (for qualified business accounts only). Register at http://manhattanresearch.webex.com.

Other Manhattan Research Products and Services

Manhattan Research conducts annual research studies among physicians and consumers, including Taking the Pulse(R), Taking the Pulse(R) Europe, Taking the Pulse(R) Asia, Cybercitizen(R) Health, Cybercitizen(R) Health Europe, and ePharma Consumer(R). Each study serves a unique purpose and focuses on different aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analysis among more than 80 consumer therapeutic segments and 25 physician specialist segments.

Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory firm for pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com, email or call 1.888.680.0800. sales@manhattanresearch.com

 

    For more information, contact:

    Maureen Malloy
    Manhattan Research
    212.255.7799
    mmalloy@manhattanresearch.com

CONTACT: Maureen Malloy of Manhattan Research, +1-212-255-7799, mmalloy@manhattanresearch.com

Web site: http://www.manhattanresearch.com/http://manhattanresearch.webex.com/

Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Posted: August 2008


View comments

Hide
(web1)